Stay updated on Dara-CyBorD in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.

Latest updates to the Dara-CyBorD in Myeloma: Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section listing participating U.S. states (Alabama, Arizona, Arkansas, California, Colorado, Illinois, Indiana, Kentucky, Maryland, Michigan, Nebraska, New Jersey, New York, Ohio, Oregon, South Carolina, Texas, Washington) and updated to revision v3.3.3. Removed the prior state entries and the HHS Vulnerability Disclosure notice (v3.3.2).SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedPublication section updated to state that PubMed entries are auto-filled and may not be about the study, and the revision note now shows version v3.3.2, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics'; removed the government funding lapse notice.SummaryDifference0.4%

- Check54 days agoChange DetectedRemoved related topics 'Multiple myeloma' and 'MedlinePlus Genetics' from the page; this does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedRemoved a MedlinePlus Genetics topic on multiple myeloma, reducing content related to that specific medical topic.SummaryDifference0.2%

- Check82 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

Stay in the know with updates to Dara-CyBorD in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.